Triple Antibiotic
- Product NDC
- 47682-392
- 11-digit product format
- 476820392
- Labeler code
- 47682
- Product ID
- 47682-392_3e4ee639-9af3-38c5-e063-6394a90a9ad3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- bacitracin zinc, neomycin sulfate, polymyxin b sulfate
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Unifirst First Aid Corporation
- Application
- M004
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2013-04-12
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
- Active strength
- 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 47682-392 | 47682-392-12 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 47682-392 | 47682-392-71 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 47682-392-12 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 47682-392-71 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 47682-392-71 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 47682-392-12 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 47682-392-71 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 47682-392-12 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 47682-392-71 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 47682-392-12 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 47682-392-71 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 47682-392-12 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 47682-392-71 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 47682-392-12 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 47682-392-71 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 47682-392-12 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 47682-392-71 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 47682-392-12 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 47682-392-71 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 47682-392-12 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 47682-392-71 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 47682-392-12 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 47682-392-71 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 47682-392-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 47682-392-71 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 47682-392-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Triple Antibiotic
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BACITRACIN ZINC | 400 [USP'U]/g |
| NEOMYCIN SULFATE | 3.5 mg/g |
| POLYMYXIN B SULFATE | 5000 [USP'U]/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89Y4M234ES | Internal UNII lookup |
| 057Y626693 | Internal UNII lookup |
| 19371312D4 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 204602 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 99e684e6-f435-feb8-d2bb-3a546f1cb768 | Product name | 2 | 20161117 |
| 25340b3b-3e4c-4ff8-abf6-3e62ec46bd0c | Product name | 1 | 20160603 |
| 2d352c73-a357-4193-a4de-dfdf9a2ac8e4 | Product name | 1 | 20150819 |
| b045ad64-0f28-9a02-2f9b-b34d94fb2278 | Product name | 1 | 20140508 |
| b6082387-f592-1148-0844-bd068fd213fb | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47682-392-12 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 | |
| 47682-392-12 | Triple Antibiotic | 10 in 1 BOX | OINTMENT | 10 | 14 | |
| 47682-392-35 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 | |
| 47682-392-35 | Triple Antibiotic | 144 in 1 BAG | OINTMENT | 144 | 14 | |
| 47682-392-71 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 | |
| 47682-392-71 | Triple Antibiotic | 20 in 1 BOX | OINTMENT | 20 | 14 | |
| 47682-392-73 | Triple Antibiotic | 25 in 1 BOX, UNIT-DOSE | OINTMENT | 25 | 14 | |
| 47682-392-99 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 47682-392 | TRIPLE ANTIBIOTIC (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE) OINTMENT [UNIFIRST FIRST AID CORPORATION] | 13 | Current NDC, Legacy NDC, 8 package rows | 20250210_d7c1a10e-c38d-4ae8-9a27-c07c2208ca84.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | NuCare Pharmaceutical, Inc. | 5b14499e-e45c-7c05-e063-6294a90a1cc2 | 2026-09-09 | Warnings | M004 |
| American Safety and First Aid Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | eb0df2da-1688-c477-e053-2995a90a74a2 | 2026-09-07 | Warnings | M004 |
| American Safety and First Aid Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | eb0d108f-42bf-3364-e053-2a95a90a4542 | 2026-09-07 | Warnings | M004 |
| MEDI-FIRST | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | f4e4d0a4-b90c-99b0-e053-2995a90ab423 | 2026-09-04 | Warnings | M004 |
| Lil Drug Store Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | ORAZEN INC | e6e5263b-328f-4775-9fac-34302f050ce0 | 2026-09-04 | Warnings | M004 |
| MEDI-FIRST | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | f4e42c5c-e080-4efb-e053-2a95a90af52e | 2026-09-04 | Warnings | M004 |
| MEDI-FIRST | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | f4e4854a-ee01-df72-e053-2995a90aa8ea | 2026-09-04 | Warnings | M004 |
| Circle K Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | ORAZEN INC | 84c3f7e4-b28b-40bb-8d9d-7c8d679e3a3a | 2026-09-04 | Warnings | M004 |
| First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HCL | Walgreen Company | b982091a-5aa0-4bbc-bb1d-08016f6d0a70 | 2026-09-03 | Warnings | M004 |
| SurviveX Triple Antibiotic | TRIPLE ANTIBIOTIC | Nantong Health & Beyond Hygienic Products Inc. | 5a7cb52d-a60c-b947-e063-6394a90afb0d | 2026-09-02 | Warnings | M004 |
| triple antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Walgreen Company | 4f3cfe39-2df8-48b4-954d-5997217c92ba | 2026-08-31 | Warnings | M004 |
| First Aid Antibiotic | BACITRACIN ZINC | NINGBO TIANBO FIRST AID PRODUCT CO., LTD. | 217aa2b8-94f5-468a-99b4-52824a77b573 | 2026-08-28 | Warnings | M004 |
| OP Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Yiwu Ori-Power Medtech Co., Ltd. | 03f3cce9-7e9f-90a6-e063-6294a90a660b | 2026-08-28 | Warnings | M004 |
| Alcare Extra Hand Sanitizer | ALCOHOL | SC Johnson Professional USA Inc. | 5dc007a2-61fa-4115-a82c-1aa489a6bd39 | 2026-08-27 | Warnings | M004 |
| InstantFoam Complete PURE | ALCOHOL | SC Johnson Professional USA Inc. | 398ca23c-7202-4670-be14-9829675f7174 | 2026-08-27 | Warnings | M004 |
| Be Smart Get Prepared Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Total Resources International, Inc | 57ed1a03-7e1b-4eb4-8001-dfd118805edc | 2026-08-24 | Warnings | M004 |
| Claravie | BACITRACIN ZINC | Gentell LLC | 59c5a363-6d79-d07e-e063-6294a90a8753 | 2026-08-24 | Warnings | M004 |
| Claravie | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B | Gentell LLC | 597cb2f0-ff05-a1ab-e063-6294a90acda9 | 2026-08-20 | Warnings | M004 |
| Medpride First Aid | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE | Shield Line LLC | 5ba3e703-7873-4724-a0bf-bb22d8a25748 | 2026-08-18 | Warnings | M004 |
| Medpride First Aid | BACITRACIN ZINC | Shield Line LLC | e6a6fb0f-5ab7-4647-84a0-7b9948eed303 | 2026-08-18 | Warnings | M004 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment | PSN | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 14 |
| 204602 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment | SCD | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 14 |
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment | SY | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 14 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 47682-392-12 | 47682039212 | 0.5 g in 1 PACKET | 0.5 g | Historical | ||||
| 47682-392-35 | 47682039235 | 144 PACKET in 1 BAG (47682-392-35) / .5 g in 1 PACKET | 144 packet | 2017-06-30 | 0000-00-00 | No | No | Current |
| 47682-392-71 | 47682039271 | 0.5 g in 1 PACKET | 0.5 g | Historical | ||||
| 47682-392-73 | 47682039273 | 25 PACKET in 1 BOX, UNIT-DOSE (47682-392-73) / .5 g in 1 PACKET (47682-392-99) | 25 packet | 2016-06-06 | 0000-00-00 | No | No | Current |
| 47682-392-99 | 47682039299 | .5 g in 1 PACKET (47682-392-99) | 2013-04-12 | No | No | Current |